SciQReg Consulting (On behalf of Sato Pharmaceutical Canada Inc.)
201-4990 McGeer Street
Vancouver
V5R 6C1
British Columbia
CANADA
Marketing Authorization Holder
N/A
Tablet
No market authorization
1,2,3,5/4,6- hexahydroxycyclohexane 40.0 mg
Introduction
Recalled Products
Shinkei
Reason
Product was sold without a valid market authorization and label claim indicated relief of menopausal symptoms. The product was not labelled in official language (English or French).